SK bioscience aims to boost competence with cell-based flu vaccine
ANDONG - SK bioscience's L HOUSE plant in Andong, 270 kilometers southeast of Seoul, played a key role in protecting lives during the pandemic by producing COVID-19 vaccines. The Korean vaccine maker said Tuesday that sales of its SKYCellflu influenza vaccine began in Korea, Wednesday.